Skip to main content

BioCommunique Article

Bringing you the latest financial and strategic news from top leaders in life science over the past two weeks.

Human Longevity Raises $30M; Merck Buys Calporta for $576M; Daré Acquires Microchips Biotech

  • 2019-11-14T22:02:00.000+0000
  • California
  • Author: Lauren Panetta

11/14/19 – EvoFem Biosciences
Evofem Biosciences' CEO Saundra Pelletier Awarded 2019 Business Woman Of The Year

11/13/19 – Human Longevity
World Expert in Genetics Joins Human Longevity as Chief Medical Officer

11/12/19 – The San Diego Union-Tribune
Merck buys San Diego’s Calporta for up to $576 million

11/12/19 – Recognized as One of North America’s Fastest-Growing Companies by Deloitte

11/11/19 – SD Business Journal
After Valuation Plummet, Human Longevity Raises $30M

11/11/19 – FierceBiotech
Invitae buys DNA chatbot developer Clear Genetics for $50M

11/11/19 – Daré Bioscience
Daré Bioscience Enters into Agreement to Acquire Microchips Biotech Including Its First-in-Class Wireless, User-Controlled Drug Delivery Platform

11/11/19 – FierceBiotech
Bolt Bio preps trials of immune-stimulating cancer drug

11/11/19 – GEN
Celgene, Acceleron Win FDA OK for Drug to Treat Anemia in Adults with Beta Thalassemia

11/11/19 – FierceBiotech
AASLD: Gilead wants to move the needle for fatty liver therapies

11/11/19 – Xconomy
Roche Challenger to Biogen’s SMA Drug Succeeds in Pivotal Study

11/8/19 – FierceBiotech
10x Genomics posts 67% growth in Q3, its first report since IPO

11/8/19 – Xconomy
Looking to Level Up in NASH, Novo Nordisk Licenses Ube Drug Candidate

11/7/19 – FierceBiotech
Celgene posts pivotal CAR-T data ahead of FDA filing

11/6/19 – Xconomy
Biogen Adds Two More Biosimilars in $100M Deal with Samsung Bioepis

11/6/19 – FierceBiotech
Merck, BMS chip in to PathAI raise, bringing total to $75M

11/6/19 – FierceBiotech
Thermo Fisher's new genetic sequencer to offer same-day results

11/5/19 – Fluidigm
Fluidigm Drives a New Standard in Human Immune Profiling

11/5/19 – FierceBiotech
Cancer biotech A2 Biotherapeutics uncloaks with $57M

11/5/19 – Takeda
Takeda and MD Anderson Announce Collaboration to Accelerate the Development of Clinical-Stage, Off-The-Shelf CAR NK-Cell Therapy Platform

11/4/19 – FierceBiotech
Rejuvenate Bio posts data on gene therapy to fend off aging

11/4/19 – The San Diego Union-Tribune
Salk Institute gets record $89 million from donors in FY 2019

11/4/19 – FierceBiotech
Scanwell launches at-home smartphone test for UTIs

11/1/19 – FierceBiotech
Dogs help Lilly scientists identify new osteoarthritis target